Cyrus Desouza, MBBS
Professor, Internal Medicine Division of Diabetes, Endocrine & Metabolism
University of Nebraska Medical Center
Omaha, Nebraska
What are the physiologic and clinical properties of incretin system-targeting agents?
What are the physiologic and clinical properties of incretin system-targeting agents?
What are the multi-factorial effects of GLP-1 RAs?
What is the physiologic and clinical rationale for combining basal insulin and a GLP-1 RA as a treatment strategy for T2D?